CCM
Camber Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,400,000
| Closed | -$18.1M | – | 30 |
|
|
2020
Q3 | $18.1M | Hold |
1,400,000
| – | – | 0.96% | 27 |
|
|
2020
Q2 | $20.4M | Sell |
1,400,000
-78,753
| -5% | -$1.15M | 1.17% | 23 |
|
|
2020
Q1 | $12.6M | Sell |
1,478,753
-1,471,247
| -50% | -$12.5M | 0.75% | 25 |
|
|
2019
Q4 | $48.6M | Hold |
2,950,000
| – | – | 2.47% | 20 |
|
|
2019
Q3 | $41.7M | Buy |
2,950,000
+950,000
| +48% | +$13.4M | 2.19% | 18 |
|
|
2019
Q2 | $40.2M | Hold |
2,000,000
| – | – | 1.87% | 19 |
|
|
2019
Q1 | $79.5M | Buy |
2,000,000
+100,000
| +5% | +$3.98M | 3.96% | 9 |
|
|
2018
Q4 | $66M | Buy |
1,900,000
+280,000
| +17% | +$9.73M | 3.13% | 11 |
|
|
2018
Q3 | $67M | Hold |
1,620,000
| – | – | 2.87% | 12 |
|
|
2018
Q2 | $59.5M | Buy |
1,620,000
+3,310
| +0.2% | +$122K | 2.29% | 17 |
|
|
2018
Q1 | $63.1M | Buy |
1,616,690
+1,081,190
| +202% | +$42.2M | 3.1% | 13 |
|
|
2017
Q4 | $9.69M | Hold |
535,500
| – | – | 0.47% | 26 |
|
|
2017
Q3 | $8.86M | Hold |
535,500
| – | – | 0.56% | 21 |
|
|
2017
Q2 | $7.5M | Buy |
535,500
+410,500
| +328% | +$5.75M | 0.37% | 28 |
|
|
2017
Q1 | $2.57M | Buy |
+125,000
| New | +$2.57M | 0.1% | 28 |
|